Jiang Li-Li, Lo Yat-Tung, Chen Wei-Ting, Shaw Pang-Chui
State Key Laboratory of Phytochemistry and Plant Resources in West China (CUHK), The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
State Key Laboratory of Phytochemistry and Plant Resources in West China (CUHK), The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China; School of Life Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
J Pharm Biomed Anal. 2016 Sep 10;129:398-404. doi: 10.1016/j.jpba.2016.07.030. Epub 2016 Jul 18.
Concentrated Chinese medicine granules (CCMG) offer patients a convenient option for traditional therapy. However with morphological and microscopic characteristics lost, it is difficult to authenticate and control the quality of these medicinal products. This study is the first to examine the feasibility of using DNA techniques to authenticate animal-derived CCMG, which has so far lacking of effective means for authentication. Primers targeting amplicons of different sizes were designed to determine the presence of PCR-amplifiable DNA fragments in two types of CCMG, namely Zaocys and Scorpio. Species-specific primers were designed to differentiate the genuine drugs from their adulterants. The specificity of the designed primers was evaluated in crude drugs (including genuine and adulterant) and CCMG. Results showed that by using species-specific primers, DNA fragments of less than 200bp could be isolated from the CCMG and the concerned source materials. This study demonstrated the presence of small size DNA in animal-derived CCMG and the DNA is effective in species identification. The work has extended the application of DNA techniques in herbal medicine and this approach may be further developed for quality control and regulatory compliance in the CCMG industry.
中药配方颗粒为患者提供了一种传统疗法的便捷选择。然而,由于失去了形态和微观特征,这些药品的真伪鉴定和质量控制变得困难。本研究首次探讨了使用DNA技术鉴定动物源中药配方颗粒的可行性,目前此类颗粒缺乏有效的鉴定方法。设计了针对不同大小扩增子的引物,以确定两种中药配方颗粒(即乌梢蛇和全蝎)中是否存在可进行PCR扩增的DNA片段。设计了物种特异性引物,以区分正品药物与其掺假品。在生药(包括正品和掺假品)和中药配方颗粒中评估了所设计引物的特异性。结果表明,通过使用物种特异性引物,可以从中药配方颗粒和相关原料中分离出小于200bp的DNA片段。本研究证明了动物源中药配方颗粒中存在小尺寸DNA,且该DNA在物种鉴定中有效。这项工作扩展了DNA技术在草药中的应用,这种方法可能会在中药配方颗粒行业中进一步发展,用于质量控制和合规监管。